Results 121 to 130 of about 29,549 (204)

ROS1 Gene Amplification [PDF]

, 2020
openaire   +1 more source

ROS1 Gene Translocation [PDF]

, 2020
openaire   +1 more source

First Report of Entrectinib as a Treatment Option for Pure Squamous Cell Carcinoma Harboring <i>ROS1</i> Rearrangement: Exploring the Role of Next-Generation Sequencing in Targeted Therapy. [PDF]

Int J Mol Sci
Tang YJ, Chen RH, Lu YS, Wu CE.
europepmc   +1 more source

Neurological adverse events of ROS1 inhibitors for non-small cell lung cancer: data from the FDA adverse event reporting system. [PDF]

Front Neurol
Wei X, Lai Q, Zheng L.
europepmc   +1 more source

Long‐term effects of crizotinib in ALK‐positive tumors (excluding NSCLC): A phase 1b open‐label study [PDF]

, 2018
et al,, Gambacorti-Passerini, Carlo, Van Tine, Brian A   +2 more
core   +1 more source

ROS1 wt Allele [PDF]

, 2020
openaire   +1 more source

Crizotinib-induced hyperlipidemia in advanced lung adenocarcinoma: A case report and literature review. [PDF]

Medicine (Baltimore)
Ren S, Chen R.
europepmc   +1 more source

ROS1 mutation

, 2019
Yuranga Weerakkody, Rohit Sharma, Daniel Bell   +2 more
openaire   +1 more source

Evolving Therapeutic Landscape of ROS1-Positive Non-Small Cell Lung Cancer: An Updated Review. [PDF]

Curr Oncol
Bischoff H, Gendarme S, Somme L, Chouaid C, Schott R.   +4 more
europepmc   +1 more source

ROS1 Rearrangement Analysis [PDF]

, 2020
openaire   +1 more source